{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:57:39Z","timestamp":1790888259073,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Global Health"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.langlo.2026.104079","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:17:31Z","timestamp":1790885851000},"page":"104079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Symptom-agnostic endpoints in tuberculosis vaccine efficacy trials"],"prefix":"10.1016","author":[{"given":"Morten","family":"Ruhwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4181-058X","authenticated-orcid":false,"given":"Alemnew F","family":"Dagnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Penn-Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto L","family":"Garcia-Basteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A","family":"Hanekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hatherill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinout","family":"van Crevel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"den Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-1730","authenticated-orcid":false,"given":"Patricia","family":"Hall-Eidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rein M G J","family":"Houben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cobelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-4065","authenticated-orcid":false,"given":"Katherine C","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4410-6635","authenticated-orcid":false,"given":"Richard G","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.langlo.2026.104079_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00127-7","article-title":"Implications of subclinical tuberculosis for vaccine trial design and global effect","volume":"5","author":"Churchyard","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.langlo.2026.104079_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0044-2022","article-title":"End-point definition and trial design to advance tuberculosis vaccine development","volume":"31","author":"Garcia-Basteiro","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.langlo.2026.104079_bib7","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.langlo.2026.104079_bib8","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.langlo.2026.104079_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S2213-2600(25)00164-X","article-title":"Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials","volume":"13","author":"White","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.langlo.2026.104079_bib11","doi-asserted-by":"crossref","first-page":"e1869","DOI":"10.1016\/S2214-109X(25)00276-1","article-title":"Screening for asymptomatic tuberculosis among adults with household exposure to a patient with pulmonary tuberculosis","volume":"13","author":"Mendelsohn","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.langlo.2026.104079_bib12","doi-asserted-by":"crossref","first-page":"e830","DOI":"10.1093\/cid\/ciaa1402","article-title":"Subclinical tuberculosis disease-a review and analysis of prevalence surveys to inform definitions, burden, associations, and screening methodology","volume":"73","author":"Frascella","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101237","article-title":"Whom tuberculosis tests detect and why it matters: implications for diagnostic algorithms","volume":"6","author":"Kendall","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.langlo.2026.104079_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2027160","article-title":"The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review","volume":"18","author":"Mohammed","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.langlo.2026.104079_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(25)00536-5","article-title":"Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study","volume":"26","author":"Sung","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib17","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/cid\/ciac185","article-title":"Recurrent subclinical tuberculosis among antiretroviral therapy\u2013accessing participants: incidence, clinical course, and outcomes","volume":"75","author":"Naidoo","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib18","article-title":"Role of tuberculosis symptoms in transmission risk to cell contacts in prisons","volume":"3","author":"da Silva Peres Bezerra","year":"2025","journal-title":"BMJ Public Health"},{"key":"10.1016\/j.langlo.2026.104079_bib19","series-title":"Report of the WHO consultation on asymptomatic tuberculosis","year":"2025"},{"key":"10.1016\/j.langlo.2026.104079_bib20","author":"McQuaid"},{"key":"10.1016\/j.langlo.2026.104079_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103928","article-title":"Mind the gap \u2013 managing tuberculosis across the disease spectrum","volume":"78","author":"Esmail","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.langlo.2026.104079_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282125","article-title":"Healthcare seeking patterns for TB symptoms: findings from the first national TB prevalence survey of South Africa, 2017\u20132019","volume":"18","author":"Moyo","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.langlo.2026.104079_bib24","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1093\/cid\/ciaf611","article-title":"Reported tuberculosis symptoms: an inadequate classifier of disease state","volume":"82","author":"McCreesh","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.langlo.2026.104079_bib26","first-page":"CD009593","article-title":"Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults","volume":"2014","author":"Steingart","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.langlo.2026.104079_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00812-17","article-title":"The new Xpert MTB\/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing","volume":"8","author":"Chakravorty","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.langlo.2026.104079_bib30","article-title":"Cumulative TB disease burden following sputum Xpert Ultra \u2018Trace\u2019 results in clinical settings: results from a multi-site observational clinical study","author":"Dalmat","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.langlo.2026.104079_bib32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2509761","article-title":"Pulmonary tuberculosis detection with MiniDock MTB using swab samples","volume":"394","author":"Yerlikaya","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.langlo.2026.104079_bib33","article-title":"Tongue swab Mycobacterium tuberculosis qPCR for community screening of asymptomatic TB vs. clinic-based triage of symptomatic TB","author":"Wood","year":"2026","journal-title":"medRxiv"},{"key":"10.1016\/j.langlo.2026.104079_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105991","article-title":"Diagnostic accuracy of swab-based molecular tests for tuberculosis using novel near point-of-care platforms: a multi-country evaluation","volume":"121","author":"Steadman","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.langlo.2026.104079_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5588\/ijtld.25.0793","article-title":"Novel near-point-of-care tuberculosis molecular tests: navigating the repercussions of sensitivity tradeoffs","volume":"30","author":"Kendall","year":"2026","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib36","article-title":"Diagnostic performance of the Pluslife MiniDock MTB and molbio MTB ultima assays to detect tuberculosis from tongue and sputum swabs among outpatients and in active case finding in Cameroon","author":"Mbuli","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cmi.2025.11.010","article-title":"Diagnostic accuracy of a novel point-of-care tongue swab assay for pulmonary tuberculosis: a multicentre prospective study","volume":"32","author":"Wu","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.langlo.2026.104079_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103939","article-title":"Reimagining the status quo: how close are we to rapid sputum-free tuberculosis diagnostics for all?","volume":"78","author":"Nathavitharana","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.langlo.2026.104079_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.langlo.2026.104079_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S2213-2600(24)00028-6","article-title":"Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise","volume":"12","author":"Coussens","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.langlo.2026.104079_bib43","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/QAD.0000000000000278","article-title":"Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped","volume":"28","author":"Ahmad Khan","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.langlo.2026.104079_bib44","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/429825","article-title":"High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania","volume":"40","author":"Mtei","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.102517","article-title":"Present outlooks on the prevalence of minimal and subclinical tuberculosis and current diagnostic tests: a systematic review and meta-analysis","volume":"17","author":"Mahmoudi","year":"2024","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.langlo.2026.104079_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101330","article-title":"Multicountry assessment of tongue swabs for tuberculosis using a common protocol for Xpert MTB\/RIF Ultra testing: a prospective diagnostic accuracy study","volume":"7","author":"de Vos","year":"2026","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.langlo.2026.104079_bib47","series-title":"Transformation of the clinical trial enterprise: lessons learned from the COVID-19 pandemic: final report","article-title":"Decentralized clinical trials and digital health technologies","author":"Stern","year":"2024"},{"key":"10.1016\/j.langlo.2026.104079_bib48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/cts.12834","article-title":"Remote monitoring in clinical trials during the COVID-19 pandemic","volume":"13","author":"Izmailova","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.langlo.2026.104079_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01493-2024","article-title":"Rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in adults: a prospective multicentre study","volume":"65","author":"Wang","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.langlo.2026.104079_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-026-14974-5","article-title":"\u201cThat is why I trust\u201d: a qualitative study on acceptability and feasibility of novel tongue swab diagnostics to assess people presenting with tuberculosis symptoms in Viet Nam and Zambia","author":"Sales","year":"2026","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.langlo.2026.104079_bib51","article-title":"Assessment of Minidock MTB for the diagnosis of tuberculosis from sputum in patients presenting to health facilities in Indonesia","author":"Hartati","year":"2026","journal-title":"medRxiv"},{"key":"10.1016\/j.langlo.2026.104079_bib53","article-title":"WHO target product profile for TB detection at peripheral settings: 2024 update","volume":"5","author":"Kohli","year":"2025","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/j.langlo.2026.104079_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01234-18","article-title":"Toward the development of a circulating free DNA-based in vitro diagnostic test for infectious diseases: a review of evidence for tuberculosis","volume":"57","author":"Fern\u00e1ndez-Carballo","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.langlo.2026.104079_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5588\/ijtld.24.0353","article-title":"Multigene Mycobacterium tuberculosis cell-free DNA assay","volume":"29","author":"Ayalew","year":"2025","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib56","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/s41467-023-37183-8","article-title":"Genome-wide tiled detection of circulating Mycobacterium tuberculosis cell-free DNA using Cas13","volume":"14","author":"Thakku","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.langlo.2026.104079_bib57","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5588\/ijtld.21.0055","article-title":"Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients","volume":"25","author":"Pollock","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp6411","article-title":"Rapid tuberculosis diagnosis from respiratory or blood samples by a low cost, portable lab-in-tube assay","volume":"17","author":"Youngquist","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.langlo.2026.104079_bib59","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1473-3099(22)00149-9","article-title":"Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017\u201319: a multistage, cluster-based, cross-sectional survey","volume":"22","author":"Moyo","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib60","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1164\/rccm.202101-0117OC","article-title":"Precision-enhancing risk stratification tools for selecting optimal treatment durations in tuberculosis clinical trials","volume":"204","author":"Imperial","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.langlo.2026.104079_bib61","first-page":"1327","article-title":"Capacity building in sub-Saharan Africa as part of the INTENSE-TBM project during the COVID-19 pandemic","volume":"11","author":"Ariza-Vioque","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.langlo.2026.104079_bib62","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1164\/rccm.201103-0536OC","article-title":"A multisite assessment of the quantitative capabilities of the Xpert MTB\/RIF assay","volume":"184","author":"Blakemore","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.langlo.2026.104079_bib63","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1164\/rccm.201312-2140OC","article-title":"Xpert MTB\/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression","volume":"189","author":"Hanrahan","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.langlo.2026.104079_bib64","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.langlo.2026.104079_bib65","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1469-0691.2011.03626.x","article-title":"Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents","volume":"18","author":"Diacon","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.langlo.2026.104079_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(23)00097-8","article-title":"The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis","volume":"11","author":"Sossen","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.langlo.2026.104079_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101672","article-title":"Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies","volume":"65","author":"Tiwari","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.langlo.2026.104079_bib71","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.langlo.2026.104079_bib72","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.langlo.2026.104079_bib74","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.vaccine.2004.07.046","article-title":"Efficacy and other milestones for human papillomavirus vaccine introduction","volume":"23","author":"Pagliusi","year":"2004","journal-title":"Vaccine"}],"container-title":["The Lancet Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214109X2600241X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214109X2600241X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:17:38Z","timestamp":1790885858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214109X2600241X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"alternative-id":["S2214109X2600241X"],"URL":"https:\/\/doi.org\/10.1016\/j.langlo.2026.104079","relation":{},"ISSN":["2214-109X"],"issn-type":[{"value":"2214-109X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptom-agnostic endpoints in tuberculosis vaccine efficacy trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Global Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.langlo.2026.104079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104079"}}